Cai et al. [31] have confirmed that p300 can epigenetically regulate hepatocellular carcinoma (HCC) progression through acetylating metabolic enzymes, and Hou et al. [32] have pointed out that p300 can enhance NSCLC cell proliferation, migration and invasion via inducing EMT. Here, EP300 is linked to non-small cell lung carcinoma.